LDLR Genetics, Splicing and AD Risk
LDLR 遗传学、剪接和 AD 风险
基本信息
- 批准号:7440187
- 负责人:
- 金额:$ 25.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-15 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAccountingAllelesAlternative SplicingAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmino AcidsAmyloid beta-ProteinAntibodiesApolipoprotein EBindingBiologicalBlood VesselsBrainCell Surface ReceptorsCell modelCell surfaceCellsCholesterolCholesterol HomeostasisCollaborationsConditioned Culture MediaDNADepositionDiseaseDisease AssociationDisease susceptibilityDominant-Negative MutationEndosomesEnhancersEventExonsExtracellular SpaceFamilial HypercholesterolemiaFamilyFrequenciesGenderGene FusionGenesGeneticGenetic PolymorphismGenotypeGolgi ApparatusGonadal Steroid HormonesHaplotypesHomeostasisHumanImmune SeraImmunoprecipitationIn VitroIndividualKentuckyLDL Cholesterol LipoproteinsLDL-Receptor Related Protein 1LabelLifeLigand BindingLigandsLinkLipidsLipoproteinsLiverLow Density Lipoprotein ReceptorLow-Density LipoproteinsMediatingMutationNeuronsNobel PrizeNonsense CodonPatternPhenotypePhysiologic pulsePlasmaPopulationPrincipal InvestigatorProcessProtein BindingProtein IsoformsProteinsPublishingPulse takingRNA SplicingReadingRelative (related person)Religion and SpiritualityReporterReportingResearch PersonnelRisk FactorsRoleSamplingSeriesSex CharacteristicsSiteTransmembrane DomainUniversitiesVariantVesicleWestern BlottingWomanWorkapolipoprotein E-3apolipoprotein E-4basecase controldisease phenotypeextracellulargain of functiongenetic varianthuman tissuein vivoinsightmRNA Stabilitymembernovelprogramsprotein functionreceptorreceptor bindingreceptor expressionreceptor functionsugartrenduptake
项目摘要
DESCRIPTION (provided by applicant): Identifying genetic variants that significantly alter the function of critical proteins provides insights into related disease processes and possible therapies. The low density lipoprotein receptor (LDLR) is remarkable in this regard because LDLR mutations are a primary cause of familial hypercholesterolemia, i.e., loss of a single LDLR allele causes an approximately 100% increase in LDL-cholesterol levels. Although LDLR SNPs and their haplotypes have been associated with altered cholesterol levels, specific SNPs that alter LDLR function have not been identified. Functional LDLR variants may provide insights into diseases that may be associated with increased cholesterol, e.g., Alzheimer's Disease (AD). Indeed, a robust genetic factor for both cholesterol and AD is the apoE4 allele of the apoE gene. Although apoE is implicated in amyloid-beta (Abeta) deposition in Alzheimer's disease, apoE is known more widely for its role in cholesterol delivery and homeostasis; apoE4 is associated with increased LDL-cholesterol via its role as a ligand for the LDL family of cell surface receptors that mediate lipoprotein uptake. This proposal focuses on the global hypothesis that SNPs that modulate LDLR splicing or expression, and the haplotypes defined by these functional SNPs, are associated with altered cholesterol homeostasis and Alzheimer's disease. Hence, we propose the following Specific Aims: 1. Evaluate LDLR SNPs to identify those that alter LDLR splicing and /or expression, 2. Evaluate the expression and function of LDLR proteins resulting from alternative LDLR splicing. 3. Evaluate LDLR genotypes and haplotypes for their association with cholesterol homeostasis and Alzheimer's disease. Overall, this focused approach will directly evaluate the hypothesis that LDLR polymorphisms modulate LDLR splicing and expression to increase LDL-cholesterol and Alzheimer's disease odds.
描述(由申请人提供):识别显著改变关键蛋白质功能的遗传变异,可深入了解相关疾病过程和可能的治疗方法。低密度脂蛋白受体(LDLR)在这方面是显著的,因为LDLR突变是家族性高胆固醇血症的主要原因,即,单个LDLR等位基因的缺失导致LDL-胆固醇水平增加约100%。尽管LDLR单核苷酸多态性及其单倍型与胆固醇水平的改变有关,但改变LDLR功能的特异性单核苷酸多态性尚未确定。功能性LDLR变体可以提供对可能与胆固醇增加相关的疾病的了解,例如,阿尔茨海默病(AD)。事实上,胆固醇和AD的一个强有力的遗传因素是apoE基因的apoE 4等位基因。虽然apoE与阿尔茨海默病中的淀粉样蛋白-β(Abeta)沉积有关,但apoE因其在胆固醇递送和体内平衡中的作用而更广泛地为人所知; apoE 4通过其作为介导脂蛋白摄取的LDL家族细胞表面受体的配体的作用而与LDL-胆固醇增加相关。该提案集中于调节LDLR剪接或表达的SNP以及由这些功能性SNP定义的单倍型与胆固醇稳态改变和阿尔茨海默病相关的全球假设。因此,我们提出以下具体目标:1。评估LDLR SNP以识别那些改变LDLR剪接和/或表达的SNP,2.评价LDLR可变剪接产生的LDLR蛋白的表达和功能。3.评价LDLR基因型和单倍型与胆固醇稳态和阿尔茨海默病的关系。总体而言,这种集中的方法将直接评估LDLR多态性调节LDLR剪接和表达以增加LDL-胆固醇和阿尔茨海默病几率的假设。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven Estus其他文献
Steven Estus的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven Estus', 18)}}的其他基金
How does D2-CD33 reduce Alzheimer's disease risk?
D2-CD33 如何降低阿尔茨海默病风险?
- 批准号:
10038417 - 财政年份:2020
- 资助金额:
$ 25.75万 - 项目类别:
The surprising impact of APOE alleles on gut microbiome: does altering the microbiome reduce AD risk?
APOE 等位基因对肠道微生物组的惊人影响:改变微生物组是否可以降低 AD 风险?
- 批准号:
9783096 - 财政年份:2018
- 资助金额:
$ 25.75万 - 项目类别:
Translating CD33 genetic mechanism into a novel Alzheimers therapeutic
将 CD33 遗传机制转化为新型阿尔茨海默病治疗方法
- 批准号:
8696452 - 财政年份:2014
- 资助金额:
$ 25.75万 - 项目类别:
Translating CD33 genetic mechanism into a novel Alzheimers therapeutic
将 CD33 遗传机制转化为新型阿尔茨海默病治疗方法
- 批准号:
9251728 - 财政年份:2014
- 资助金额:
$ 25.75万 - 项目类别:
Translating CD33 genetic mechanism into a novel Alzheimers therapeutic
将 CD33 遗传机制转化为新型阿尔茨海默病治疗方法
- 批准号:
9038210 - 财政年份:2014
- 资助金额:
$ 25.75万 - 项目类别:
Urokinase-type plasminogen activator and Alzheimer's
尿激酶型纤溶酶原激活剂与阿尔茨海默病
- 批准号:
6656286 - 财政年份:2002
- 资助金额:
$ 25.75万 - 项目类别:
相似海外基金
Impact of alternative polyadenylation of 3'-untranslated regions in the PI3K/AKT cascade on microRNA
PI3K/AKT 级联中 3-非翻译区的替代多聚腺苷酸化对 microRNA 的影响
- 批准号:
573541-2022 - 财政年份:2022
- 资助金额:
$ 25.75万 - 项目类别:
University Undergraduate Student Research Awards
How do untranslated regions of cannabinoid receptor type 1 mRNA determine receptor subcellular localisation and function?
1 型大麻素受体 mRNA 的非翻译区如何决定受体亚细胞定位和功能?
- 批准号:
2744317 - 财政年份:2022
- 资助金额:
$ 25.75万 - 项目类别:
Studentship
MICA:Synthetic untranslated regions for direct delivery of therapeutic mRNAs
MICA:用于直接递送治疗性 mRNA 的合成非翻译区
- 批准号:
MR/V010948/1 - 财政年份:2021
- 资助金额:
$ 25.75万 - 项目类别:
Research Grant
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10019570 - 财政年份:2019
- 资助金额:
$ 25.75万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10223370 - 财政年份:2019
- 资助金额:
$ 25.75万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10455108 - 财政年份:2019
- 资助金额:
$ 25.75万 - 项目类别:
Synergistic microRNA-binding sites, and 3' untranslated regions: a dialogue of silence
协同的 microRNA 结合位点和 3 非翻译区:沉默的对话
- 批准号:
255762 - 财政年份:2012
- 资助金额:
$ 25.75万 - 项目类别:
Operating Grants
Analysis of long untranslated regions in Nipah virus genome
尼帕病毒基因组长非翻译区分析
- 批准号:
20790351 - 财政年份:2008
- 资助金额:
$ 25.75万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Search for mRNA elements involved in the compatibility between 5' untranslated regions and coding regions in chloroplast translation
寻找参与叶绿体翻译中 5 非翻译区和编码区之间兼容性的 mRNA 元件
- 批准号:
19370021 - 财政年份:2007
- 资助金额:
$ 25.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Post-transcriptional Regulation of PPAR-g Expression by 5'-Untranslated Regions
5-非翻译区对 PPAR-g 表达的转录后调控
- 批准号:
7131841 - 财政年份:2006
- 资助金额:
$ 25.75万 - 项目类别: